Cell Source Operating Expenses Growth & History (CLCS)

Cell Source's operating expenses was $3.8M for fiscal 2024.

View full Cell Source company overview

Cell Source annual operating expenses history

Cell Source annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20242024-12-31$3.8M−$485,102−11.22%
20232023-12-31$4.3M$150,013+3.59%
20222022-12-31$4.2M$156,761+3.90%
20212021-12-31$4.0M$380,536+10.46%
20202020-12-31$3.6M−$167,165−4.39%
20192019-12-31$3.8M$1.8M+89.68%
20182018-12-31$2.0M−$286,660−12.50%
20172017-12-31$2.3M−$25,803−1.11%
20162016-12-31$2.3M−$1,869−0.08%
20152015-12-31$2.3M−$1.7M−42.76%
20142014-12-31$4.1M$2.6M+178.56%
20132013-12-31$1.5M

Cell Source operating expenses trends

Over the last five fiscal years, Cell Source's operating expenses increased from $3.8M to $3.8M, a change of $35,043. The latest reported quarter, Q1 2025, shows $998,587.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cell Source source filings ↗

Community posts

It’s quiet here.

No posts about CLCS yet. Start the conversation.

Write the first post